Issa F Khouri (Issa Khouri)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 29

Top Topics

Prognostic Factors

Stem Cell Transplantation

Top Venues

American journal of hematology

Bone marrow transplantation

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Alexandre E Malek, Taha Al-Juhaishi, Denái R Milton, Jeremy L Ramdial, May Daher, Amanda L Olson, Samer A Srour, Gheath Alatrash, Betul Oran, Rohtesh S Mehta, Issa F Khouri, Qaiser Bashir, Nina Shah, Stefan O Ciurea, Gabriela Rondon, Farzaneh Maadani, Chitra Hosing, David Marin, Partow Kebriaei, Katayoun Rezvani, Yago Nieto, Paolo Anderlini, Amin M Alousi, Muhammad Salman Faisal, Muzaffar H Qazilbash, Uday R Popat, Richard E Champlin, Elizabeth J Shpall, Victor E Mulanovich, Sairah A Ahmed
Outcomes of toxoplasmosis after allogeneic hematopoietic stem cell transplantation and the role of antimicrobial prophylaxis. Bone marrow transplantation (2024)
Issa F Khouri, Kamal Alzahrani, Hagop M Kantarjian, Denái R Milton, Alison M Gulbis, Koiji Sasaki, Nitin Jain, Nicholas James Short, Tapan Mahendra Kadia, May Daher, Hind Rafei, Jin S Im, David Marin, Amanda L Olson, Uday R Popat, Muzaffar H Qazilbash, Jeremy Ramdial, Gabriela Rondon, Samer A Srour, Partow Kebriaei, Elizabeth Shpall, Richard Champlin, Elias J Jabbour
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial. American journal of hematology 99 (5) (2024)
Alexandre E Malek, Taha Al-Juhaishi, Denái R Milton, Jeremy L Ramdial, May Daher, Amanda L Olson, Samer A Srour, Gheath Alatrash, Betul Oran, Rohtesh S Mehta, Issa F Khouri, Qaiser Bashir, Nina Shah, Stefan O Ciurea, Gabriela Rondon, Farzaneh Maadani, Chitra Hosing, David Marin, Partow Kebriaei, Katayoun Rezvani, Yago Nieto, Paolo Anderlini, Amin M Alousi, Muhammad Salman Faisal, Muzaffar H Qazilbash, Uday R Popat, Richard E Champlin, Elizabeth J Shpall, Victor E Mulanovich, Sairah A Ahmed
Outcomes of toxoplasmosis after allogeneic hematopoietic stem cell transplantation and the role of antimicrobial prophylaxis. Bone marrow transplantation 59 (5) (2024)
Sairah Ahmed, Qaiser Bashir, Roland L Bassett, Fauzia Ullah, Fleur Aung, Benigno C Valdez, Amin M Alousi, Chitra Hosing, Partow Kebriaei, Issa F Khouri, David Marin, Yago L Nieto, Amanda L Olson, Betul Oran, Muzaffar H Qazilbash, Katayoun Rezvani, Rohtesh S Mehta, Elizabeth J Shpall, Stefan O Ciurea, Borje S Andersson, Richard E Champlin, Uday R Popat
Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II study. American journal of hematology (2024)
Issa F Khouri, Kamal Alzahrani, Hagop M Kantarjian, Denái R Milton, Alison M Gulbis, Koiji Sasaki, Nitin Jain, Nicholas James Short, Tapan Mahendra Kadia, May Daher, Hind Rafei, Jin S Im, David Marin, Amanda L Olson, Uday R Popat, Muzaffar H Qazilbash, Jeremy Ramdial, Gabriela Rondon, Samer A Srour, Partow Kebriaei, Elizabeth Shpall, Richard Champlin, Elias J Jabbour
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial. American journal of hematology 99 (5) (2024)
Sairah Ahmed, Qaiser Bashir, Roland L Bassett, Fauzia Ullah, Fleur Aung, Benigno C Valdez, Amin M Alousi, Chitra Hosing, Partow Kebriaei, Issa F Khouri, David Marin, Yago L Nieto, Amanda L Olson, Betul Oran, Muzaffar H Qazilbash, Katayoun Rezvani, Rohtesh S Mehta, Elizabeth J Shpall, Stefan O Ciurea, Borje S Andersson, Richard E Champlin, Uday R Popat
Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II study. American journal of hematology 99 (4) (2024)
Issa F Khouri, Kamal Alzahrani, Hagop M Kantarjian, Denái R Milton, Alison M Gulbis, Koiji Sasaki, Nitin Jain, Nicholas James Short, Tapan Mahendra Kadia, May Daher, Hind Rafei, Jin S Im, David Marin, Amanda L Olson, Uday R Popat, Muzaffar H Qazilbash, Jeremy Ramdial, Gabriela Rondon, Samer A Srour, Partow Kebriaei, Elizabeth Shpall, Richard Champlin, Elias J Jabbour
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial. American journal of hematology 99 (5) (2024)
Issa F Khouri, Kamal Alzahrani, Hagop M Kantarjian, Denái R Milton, Alison M Gulbis, Koiji Sasaki, Nitin Jain, Nicholas James Short, Tapan Mahendra Kadia, May Daher, Hind Rafei, Jin S Im, David Marin, Amanda L Olson, Uday R Popat, Muzaffar H Qazilbash, Jeremy Ramdial, Gabriela Rondon, Samer A Srour, Partow Kebriaei, Elizabeth Shpall, Richard Champlin, Elias J Jabbour
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial. American journal of hematology (2024)
Issa F Khouri, Kamal Alzahrani, Hagop M Kantarjian, Denái R Milton, Alison M Gulbis, Koiji Sasaki, Nitin Jain, Nicholas James Short, Tapan Mahendra Kadia, May Daher, Hind Rafei, Jin S Im, David Marin, Amanda L Olson, Uday R Popat, Muzaffar H Qazilbash, Jeremy Ramdial, Gabriela Rondon, Samer A Srour, Partow Kebriaei, Elizabeth Shpall, Richard Champlin, Elias J Jabbour
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial. American journal of hematology 99 (5) (2024)
Sairah Ahmed, Qaiser Bashir, Roland L Bassett, Fauzia Ullah, Fleur Aung, Benigno C Valdez, Amin M Alousi, Chitra Hosing, Partow Kebriaei, Issa F Khouri, David Marin, Yago L Nieto, Amanda L Olson, Betul Oran, Muzaffar H Qazilbash, Katayoun Rezvani, Rohtesh S Mehta, Elizabeth J Shpall, Stefan O Ciurea, Borje S Andersson, Richard E Champlin, Uday R Popat
Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II study. American journal of hematology 99 (4) (2024)
Sairah Ahmed, Qaiser Bashir, Roland L Bassett, Fauzia Ullah, Fleur Aung, Benigno C Valdez, Amin M Alousi, Chitra Hosing, Partow Kebriaei, Issa F Khouri, David Marin, Yago L Nieto, Amanda L Olson, Betul Oran, Muzaffar H Qazilbash, Katayoun Rezvani, Rohtesh S Mehta, Elizabeth J Shpall, Stefan O Ciurea, Borje S Andersson, Richard E Champlin, Uday R Popat
Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II study. American journal of hematology (2024)
Alexandre E Malek, Taha Al-Juhaishi, Denái R Milton, Jeremy L Ramdial, May Daher, Amanda L Olson, Samer A Srour, Gheath Alatrash, Betul Oran, Rohtesh S Mehta, Issa F Khouri, Qaiser Bashir, Nina Shah, Stefan O Ciurea, Gabriela Rondon, Farzaneh Maadani, Chitra Hosing, David Marin, Partow Kebriaei, Katayoun Rezvani, Yago Nieto, Paolo Anderlini, Amin M Alousi, Muhammad Salman Faisal, Muzaffar H Qazilbash, Uday R Popat, Richard E Champlin, Elizabeth J Shpall, Victor E Mulanovich, Sairah A Ahmed
Outcomes of toxoplasmosis after allogeneic hematopoietic stem cell transplantation and the role of antimicrobial prophylaxis. Bone marrow transplantation 59 (5) (2024)
Sairah Ahmed, Qaiser Bashir, Roland L Bassett, Fauzia Ullah, Fleur Aung, Benigno C Valdez, Amin M Alousi, Chitra Hosing, Partow Kebriaei, Issa F Khouri, David Marin, Yago L Nieto, Amanda L Olson, Betul Oran, Muzaffar H Qazilbash, Katayoun Rezvani, Rohtesh S Mehta, Elizabeth J Shpall, Stefan O Ciurea, Borje S Andersson, Richard E Champlin, Uday R Popat
Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II study. American journal of hematology 99 (4) (2024)
Issa F Khouri, Kamal Alzahrani, Hagop M Kantarjian, Denái R Milton, Alison M Gulbis, Koiji Sasaki, Nitin Jain, Nicholas James Short, Tapan Mahendra Kadia, May Daher, Hind Rafei, Jin S Im, David Marin, Amanda L Olson, Uday R Popat, Muzaffar H Qazilbash, Jeremy Ramdial, Gabriela Rondon, Samer A Srour, Partow Kebriaei, Elizabeth Shpall, Richard Champlin, Elias J Jabbour
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial. American journal of hematology (2024)
Sairah Ahmed, Qaiser Bashir, Roland L Bassett, Fauzia Ullah, Fleur Aung, Benigno C Valdez, Amin M Alousi, Chitra Hosing, Partow Kebriaei, Issa F Khouri, David Marin, Yago L Nieto, Amanda L Olson, Betul Oran, Muzaffar H Qazilbash, Katayoun Rezvani, Rohtesh S Mehta, Elizabeth J Shpall, Stefan O Ciurea, Borje S Andersson, Richard E Champlin, Uday R Popat
Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II study. American journal of hematology 99 (4) (2024)
Elias J Jabbour, Koiji Sasaki, Fady Gh Haddad, Ghayas C Issa, Guillermo Garcia Manero, Tapan Mahendra Kadia, Nitin Jain, Musa Ylimaz, Courtney D D DiNardo, Keyur Patel, Rashmi Kanagal-Shamana, Richard Champlin, Issa F Khouri, Sara Dellasala, Sherry A Pierce, Hagop M Kantarjian
The Outcomes of Patients with Chronic Myeloid Leukemia Treated with Third-line BCR::ABL1 Tyrosine Kinase Inhibitors. American journal of hematology (2023)
Hagop M Kantarjian, Nicholas James Short, Nitin Jain, Koji Sasaki, Xuelin Huang, Fady Gh Haddad, Issa F Khouri, Courtney D D DiNardo, Naveen Pemmaraju, William Wierda, Guillermo Garcia Manero, Partow Kebriaei, Rebecca Garris, Sanam Loghavi, Jeffrey Jorgensen, Monica Kwari, Susan O'Brien, Farhad Ravandi, Elias J Jabbour
Frontline combination of ponatinib and hyper-CVAD in Philadelphia chromosome-positive acute lymphoblastic leukemia: 80-months follow-up results. American journal of hematology 98 (3) (2023)
Taha Al-Juhaishi, Yingjun Wang, Denái R Milton, Zijun Y Xu-Monette, Elias J Jabbour, May Daher, Jin S Im, Qaiser Bashir, Swaminathan P Iyer, David Marin, Amanda L Olson, Uday R Popat, Muzaffar H Qazilbash, Gabriela Rondon, Alison M Gulbis, Richard E Champlin, Ken H Young, Issa F Khouri
Clinical relevance of MYC/BCL2 expression and cell of origin in patients with diffuse large b-cell lymphoma treated with autologous transplant. Bone marrow transplantation (2023)
Elias J Jabbour, Koiji Sasaki, Fady Gh Haddad, Ghayas C Issa, Guillermo Garcia Manero, Tapan Mahendra Kadia, Nitin Jain, Musa Ylimaz, Courtney D D DiNardo, Keyur P Patel, Rashmi Kanagal-Shamana, Richard Champlin, Issa F Khouri, Sara Dellasala, Sherry A Pierce, Hagop M Kantarjian
The outcomes of patients with chronic myeloid leukemia treated with third-line BCR::ABL1 tyrosine kinase inhibitors. American journal of hematology 98 (4) (2023)
Elias J Jabbour, Koiji Sasaki, Fady Gh Haddad, Ghayas C Issa, Guillermo Garcia Manero, Tapan Mahendra Kadia, Nitin Jain, Musa Ylimaz, Courtney D D DiNardo, Keyur P Patel, Rashmi Kanagal-Shamana, Richard Champlin, Issa F Khouri, Sara Dellasala, Sherry A Pierce, Hagop M Kantarjian
The outcomes of patients with chronic myeloid leukemia treated with third-line BCR::ABL1 tyrosine kinase inhibitors. American journal of hematology 98 (4) (2023)
Hagop M Kantarjian, Nicholas James Short, Nitin Jain, Koji Sasaki, Xuelin Huang, Fady Gh Haddad, Issa F Khouri, Courtney D D DiNardo, Naveen Pemmaraju, William Wierda, Guillermo Garcia Manero, Partow Kebriaei, Rebecca Garris, Sanam Loghavi, Jeffrey Jorgensen, Monica Kwari, Susan O'Brien, Farhad Ravandi, Elias J Jabbour
Frontline combination of ponatinib and hyper-CVAD in Philadelphia chromosome-positive acute lymphoblastic leukemia: 80-months follow-up results. American journal of hematology 98 (3) (2023)
Hagop M Kantarjian, Nicholas James Short, Nitin Jain, Koji Sasaki, Xuelin Huang, Fady Gh Haddad, Issa F Khouri, Courtney D D DiNardo, Naveen Pemmaraju, William Wierda, Guillermo Garcia Manero, Partow Kebriaei, Rebecca Garris, Sanam Loghavi, Jeffrey Jorgensen, Monica Kwari, Susan O'Brien, Farhad Ravandi, Elias J Jabbour
Frontline combination of ponatinib and hyper-CVAD in Philadelphia chromosome-positive acute lymphoblastic leukemia: 80-months follow-up results. American journal of hematology (2023)
Elias J Jabbour, Koiji Sasaki, Fady Gh Haddad, Ghayas C Issa, Guillermo Garcia Manero, Tapan Mahendra Kadia, Nitin Jain, Musa Ylimaz, Courtney D D DiNardo, Keyur P Patel, Rashmi Kanagal-Shamana, Richard Champlin, Issa F Khouri, Sara Dellasala, Sherry A Pierce, Hagop M Kantarjian
The outcomes of patients with chronic myeloid leukemia treated with third-line BCR::ABL1 tyrosine kinase inhibitors. American journal of hematology (2023)
Elias J Jabbour, Koiji Sasaki, Fady Gh Haddad, Ghayas C Issa, Guillermo Garcia Manero, Tapan Mahendra Kadia, Nitin Jain, Musa Ylimaz, Courtney D D DiNardo, Keyur P Patel, Rashmi Kanagal-Shamana, Richard Champlin, Issa F Khouri, Sara Dellasala, Sherry A Pierce, Hagop M Kantarjian
The outcomes of patients with chronic myeloid leukemia treated with third-line BCR::ABL1 tyrosine kinase inhibitors. American journal of hematology 98 (4) (2023)
Hagop M Kantarjian, Nicholas James Short, Nitin Jain, Koji Sasaki, Xuelin Huang, Fady Gh Haddad, Issa F Khouri, Courtney D D DiNardo, Naveen Pemmaraju, William Wierda, Guillermo Garcia Manero, Partow Kebriaei, Rebecca Garris, Sanam Loghavi, Jeffrey Jorgensen, Monica Kwari, Susan O'Brien, Farhad Ravandi, Elias J Jabbour
Frontline combination of ponatinib and hyper-CVAD in Philadelphia chromosome-positive acute lymphoblastic leukemia: 80-months follow-up results. American journal of hematology 98 (3) (2023)
Hagop M Kantarjian, Nicholas James Short, Nitin Jain, Koji Sasaki, Xuelin Huang, Fady Gh Haddad, Issa F Khouri, Courtney D D DiNardo, Naveen Pemmaraju, William Wierda, Guillermo Garcia Manero, Partow Kebriaei, Rebecca Garris, Sanam Loghavi, Jeffrey Jorgensen, Monica Kwari, Susan O'Brien, Farhad Ravandi, Elias J Jabbour
Frontline combination of ponatinib and hyper-CVAD in Philadelphia chromosome-positive acute lymphoblastic leukemia: 80-months follow-up results. American journal of hematology 98 (3) (2023)
Amanda Olson, Ruitao Lin, David Marin, Hind Rafei, Mustafa H Bdaiwi, Peter F Thall, Rafet Basar, Ala Abudayyeh, Pinaki Banerjee, Fleur M Aung, Indresh Kaur, Glorette Abueg, Sheetal Rao, Roy F Chemaly, Victor Mulanovich, Gheath Al-Atrash, Amin M Alousi, Borje S Andersson, Paolo Anderlini, Qaiser Bashir, Karla M Castro, May Daher, Isabel M Galvan, Chitra Hosing, Jin S Im, Roy B Jones, Partow Kebriaei, Issa F Khouri, Rohtesh S Mehta, Jeffrey Molldrem, Yago L Nieto, Betül Oran, Sairah A Ahmed, Muzaffar Qazilbash, Gabriela Rondon, Neeraj Saini, Bryan Spencer, Samer Srour, Dominique Washington, Melissa Barnett, Richard E Champlin, Elizabeth J Shpall, Katayoun Rezvani
Third-Party BK Virus-Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (24) (2021)
Elias J Jabbour, Koiji Sasaki, Nicholas James Short, Farhad Ravandi, Xuelin Huang, Joseph D Khoury, Rashmi Kanagal-Shamana, Jeffrey Jorgensen, Issa F Khouri, Partow Kebriaei, Nitin Jain, Yesid Alvarado, Tapan Mahendra Kadia, Shilpa Paul, Guillermo Garcia Manero, Bouthaina Shbib Dabaja, Jan A Burger, Courtney D D DiNardo, Naval G Daver, Guillermo Montalban Bravo, Musa Yilmaz, Maro Ohanian, Alessandra Ferrajoli, Jovitta Jacob, Meagan Rostykus, Rebecca Garris, Susan O'Brien, Hagop M Kantarjian
Long-term follow-up of salvage therapy using a combination of inotuzumab ozogamicin and mini-hyper-CVD with or without blinatumomab in relapsed/refractory Philadelphia chromosome-negative acute lymphoblastic leukemia. Cancer 127 (12) (2021)
Koiji Sasaki, Hagop M Kantarjian, Nicholas James Short, Bachar Samra, Joseph D Khoury, Rashmi Kanagal-Shamana, Marina Konopleva, Nitin Jain, Courtney D D DiNardo, Rita Khouri, Guillermo Garcia Manero, Tapan Mahendra Kadia, William G Wierda, Issa F Khouri, Partow Kebriaei, Rohtesh S Mehta, Richard E Champlin, Rebecca Garris, Cora Marie Cheung, Naval G Daver, Philip A Thompson, Musa Yilmaz, Farhad Ravandi, Elias J Jabbour
Prognostic factors for progression in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia in complete molecular response within 3 months of therapy with tyrosine kinase inhibitors. Cancer 127 (15) (2021)